Ibar,
Yours is excellent advice to persons wanting to keep supporting our business.
We needed money to get us through clinical wound trials and to get hopefully USA FDA approval and then NICE stamp of approval. What is shocking is that Recell has not been approved yet by our own TGA.
So, we now have some money and some breathing space.
We can raise more money as you wisely recommend, by supporting placement offer by our business.
End of March wound clinical trial results will indicate a game changer or nothing.
The billion dollar market for Avita Medical is hopefully REGERCELL for chronic wounds, as there is nothing on the market that really works that well, in my opinion.
MB
Ibar, Yours is excellent advice to persons wanting to keep...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.06 |
Change
-0.160(4.97%) |
Mkt cap ! $215.7M | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.17 | $3.05 | $559.2K | 180.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 10230 | $3.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.07 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |